Article: Dr. Reddy. (Active Pharmaceuticals Ingredient Watch).(Dr. Reddy's Laboratories)(Brief Article)(Statistical Data Included)

Article: Active pharmaceuticals ingredient watch. (Markets: ...
Chemical Market Reporter;  February 11, 2002 ;     700+ words ...ALPHARMA INC.'s subsidiary Purepac Pharmaceutical Company has received Food & Drug Administration (FDA) approval for a generic version of Novartis Pharmaceuticals' Ritalin (methylphenidate hydrochloride) in 5 mg, 10mg and 20 mg tablets. ASTRAZENECA PLC posted underlying operating profit for the

Article: American Home Products Corp. (Active Pharmaceuticals ...
Chemical Market Reporter;  February 4, 2002 ;     501 words ...AMERICAN HOME PRODUCTS Corp. posted a 17 percent rise in fourth quarter profit of $822.7 million, or 62 cents a share, compared to $704.3 million in the prior year. Full-year sales of $3.7 billion rebounded from a $3.8 billion fee in 2000 linked to diet drug settlements.

Article: Baxter International Inc. (Active Pharmaceuticals ...
Chemical Market Reporter;  February 4, 2002 ;     684 words ...BAXTER International Inc. posted fourth quarter underlying earnings of $324 million, or 53 cents a share, up 20 percent from $270 million. Sales were $2.14 billion, up 11 percent, driven by Recombinate Antihemophilic Factor.

Article: Barr Laboratories Inc. (Active Pharmaceuticals ...
Chemical Market Reporter;  February 4, 2002 ;     574 words ...BARR Laboratories Inc. posted second quarter profit of $42.1 million, or 91 cents a share, versus 38 cents in the prior year, beating consensus by 8 cents as sales more than doubled to $366 million, on wholesaler-packed tamoxifen sales of $137 million. Also, Barr is being sued by Aventis

Article: Active Pharmaceuticals ingredient watch. (Markets: ...
Chemical Market Reporter;  January 21, 2002 ;     700+ words ...ABBOTT Laboratories reported 2001 sales of $16.3 billion, up 18.5 percent year over year, which includes US pharmaceuticals sales of $3.76 billion and international pharmaceuticals sales of $2.52 billion. ARRAY BIOPHARMA Inc. has signed a series of nonexclusive agreements to provide Pfizer Inc.

Article: Active pharmaceuticals ingredient watch. (Market: ...
Chemical Market Reporter;  January 28, 2002 ;     661 words ...ALPHARMA Inc. reports that its subsidiary Purepac Pharmaceutical Co. has received tentative approval from the FDA for generic tablets of AstraZeneca's hypertension drug Zestril (lisinopril). AMERICAN Bioscience, Inc. reports Bristol-Myers Squibb Company has instructed the FDA to delist ABI's US

Article: Novartis. (Active Pharmaceuticals Ingredient ...
Chemical Market Reporter;  February 18, 2002 ;     450 words ...NOVARTIS AG posted an 8-percent gain in 2001 net income to SFr 7 billion ($4 billion), slightly ahead of Goldman Sachs estimates, on 10 percent higher sales of SFr 32 billion. Pharmaceuticals sales grew 15 percent in local currencies.